/
BTK Inhibitors and  Cardiac Considerations in Chronic Lymphocytic Leukemia BTK Inhibitors and  Cardiac Considerations in Chronic Lymphocytic Leukemia

BTK Inhibitors and Cardiac Considerations in Chronic Lymphocytic Leukemia - PowerPoint Presentation

tawny-fly
tawny-fly . @tawny-fly
Follow
385 views
Uploaded On 2018-02-14

BTK Inhibitors and Cardiac Considerations in Chronic Lymphocytic Leukemia - PPT Presentation

Overview Overview cont Ibrutinib R elated Cardiovascular A E s Atrial Fibrillation IbrutinibRelated AF Data From 2016 ASH Conference Wiczer et al Data Risk Stratification Mechanisms of IbrutinibRelated Cardiotoxicity ID: 631473

related ibrutinib cardiovascular management ibrutinib related management cardiovascular data overview

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "BTK Inhibitors and Cardiac Consideratio..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript